Similar articles

• Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay.

  Gibson RE, Rzeszotarski WJ, Komai T, Reba RC, Eckelman WC. Gibson RE, et al. J Pharmacol Exp Ther. 1979 Apr;209(1):153-61. J Pharmacol Exp Ther. 1979. PMID: 34714 No abstract available.
• Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type.

  Erez M, Shtacher G, Weinstock M. Erez M, et al. J Med Chem. 1978 Sep;21(9):982-4. doi: 10.1021/jm00207a025. J Med Chem. 1978. PMID: 31488
• Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.

  Rzeszotarski WJ, Gibson RE, Eckelman WC, Reba RC. Rzeszotarski WJ, et al. J Med Chem. 1979 Jun;22(6):735-7. doi: 10.1021/jm00192a022. J Med Chem. 1979. PMID: 37339
• The assessment of beta-adrenoceptor blocking drugs in man.

  McDevitt DG. McDevitt DG. Br J Clin Pharmacol. 1977 Aug;4(4):413-25. doi: 10.1111/j.1365-2125.1977.tb00756.x. Br J Clin Pharmacol. 1977. PMID: 20123 Free PMC article. Review. No abstract available.
• Differential pharmacological properties of beta-adrenoceptor blocking drugs.

  van Zwieten PA, Timmermans PB. van Zwieten PA, et al. J Cardiovasc Pharmacol. 1983;5 Suppl 1:S1-7. doi: 10.1097/00005344-198300051-00001. J Cardiovasc Pharmacol. 1983. PMID: 6188914 Review.